Cargando…
Hepatoprotective Efficacy and Interventional Mechanism of Qijia Rougan Decoction in Liver Fibrosis
Liver fibrosis is a leading contributor to chronic liver diseases such as cirrhosis and liver cancer, which pose a serious health threat worldwide, and there are no effective drugs to treat it. Qijia Rougan decoction was modified from Sanjiasan, a traditional Chinese medicine (TCM) described in the...
Autores principales: | Chen, Xiao-Feng, Wang, Yumei, Ji, Shaoxiu, Sun, Xin, Feng, Quansheng, Yu, Han, Liu, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9283647/ https://www.ncbi.nlm.nih.gov/pubmed/35846987 http://dx.doi.org/10.3389/fphar.2022.911250 |
Ejemplares similares
-
Transcriptome analysis reveals the molecular mechanism of Yiqi Rougan decoction in reducing CCl(4)-induced liver fibrosis in rats
por: Xiong, Yu, et al.
Publicado: (2021) -
Revealing the Mechanism of Huazhi Rougan Granule in the Treatment of Nonalcoholic Fatty Liver Through Intestinal Flora Based on 16S rRNA, Metagenomic Sequencing and Network Pharmacology
por: Liu, Yingying, et al.
Publicado: (2022) -
Medicinal Formula Huazhi-Rougan Attenuates Non-Alcoholic Steatohepatitis Through Enhancing Fecal Bile Acid Excretion in Mice
por: Li, Chunlin, et al.
Publicado: (2022) -
Corrigendum: Revealing the mechanism of Huazhi Rougan granule in the treatment of nonalcoholic fatty liver through intestinal flora based on 16S rRNA, metagenomic sequencing and network pharmacology
por: Liu, Yingying, et al.
Publicado: (2023) -
Modified rougan decoction alleviates lipopolysaccharide-enrofloxacin-induced hepatotoxicity via activating the Nrf2/ARE pathway in chicken
por: Wang, Wenjia, et al.
Publicado: (2022)